Joseph Michael Collaco, MD

Dr. Jill A. Fahrner is an assistant professor in the Departments of Genetic Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her area of clinical expertise is medical genetics. Dr. Fahrner earned her Ph.D. from Johns Hopkins University and her M.D. from the University of North Carolina. She completed pediatrics residency training at Duke University Medical Center. She joined the McKusick-Nathans Institute of Genetic Medicine as a genetic medicine resident in 2009 and completed her training in 2012. She stayed on as chief resident from 2012-2013 and then joined the faculty as an assistant professor in the Department of Pediatrics within the McKusick-Nathans Institute of Genetic Medicine in 2013. Her current primary appointment is Assistant Professor in the Department of Genetic Medicine, where she is Director of the multidisciplinary Epigenetics and Chromatin Clinic.She is a physician-scientist with a long-standing interest in epigenetic mechanisms of disease. Her clinical focus is on caring for individuals with epigenetic and chromatin disorders, specifically Mendelian disorders of the epigenetic machinery, or chromatin modifying disorders. She has seen hundreds of individuals with congenital disorders involving disrupted epigenetics, most of which exhibit neurodevelopmental disabilities and abnormal growth. Her laboratory research is focused on understanding disease mechanisms and developing therapies for select Mendelian disorders of the epigenetic machinery.She is a member of the American Society of Human Genetics (ASHG), having won an ASHG Reviewer’s Choice Abstract Award for her work on growth retardation in Kabuki syndrome 1. She has received a Johns Hopkins School of Medicine Clinician Scientist Award, a Johns Hopkins School of Medicine Musculoskeletal Pilot and Feasibility Award, a William and Ella Owens Medical Research Foundation Award, the Margaret Ellen Nielsen Fellowship Award, and the Alice and YT Chen Travel Award while at Johns Hopkins. She is the recipient of a prestigious Hartwell Foundation Individual Biomedical Research Award and also has ongoing research funding from the National Institutes of Health.

Dr. Janet L. Crane is an Associate Professor of Pediatrics at the Johns Hopkins University School of Medicine. Dr. Crane is the Director of the Pediatric Bone Health Program, which focuses on the care of children with rare metabolic bone diseases and osteoporosis/skeletal fragility syndromes. Dr. Crane received her bachelor’s degree in nutritional science from the University of Missouri. She completed her medical degree at the University of Maryland-Baltimore, residency in pediatrics at Children's Mercy Hospital and Clinics in Kansas City, Missouri and fellowship in pediatric endocrinology at Johns Hopkins University in 2013.Dr. Crane is a faculty member of the Center for Musculoskeletal Research. Her research is focused on bone modeling and remodeling factors that result in proper bone growth and strength. The goal of her studies is to identify diagnostic markers and therapeutic targets to enhance bone strength in children who have recurrent fractures. Dr. Crane also participates in industry sponosored clinical studies to investigate the safety and efficacy of medications for metabolic bone disease and skeletal fragility.

Maria Trent, MD, MPH, FAAP, FSAHM, is a pediatrician specializing in adolescent and young adult medicine at Johns Hopkins University School of Medicine, Nursing, and Public Health. Dr. Trent is a Bloomberg Professor of American Health and serves as the inaugural Director of Adolescent and Young Adult Medicine at the Johns Hopkins Children's Center. Her peers have consistently recognized her as a "top doc" in the greater Baltimore metropolitan area. Dr. Trent is an independent scientist and is the principal investigator on various research projects, both nationally and internationally, funded by the National Institutes of Health (NIH) and other organizations. A primary focus of Dr. Trent's research and clinical interests is to reduce sexual and reproductive health disparities among adolescents and young adults. Her work explores the use of technology, community health nursing, and clinical decision-making tools for this population in practice. Moreover, she is committed to training the next generation of adolescent health scientists, leading the NIH-funded Adolescent Reproductive Health Training Program at Johns Hopkins School of Medicine. Dr. Trent previously served as the president of the Society for Adolescent Health and Medicine. Currently, she is a member of the CDC/HRSA Advisory Committee, co-leads the Institutions, Organizations, and Policies Scientific Leadership Group for the Adolescent Trials Network, and actively collaborates with Johns Hopkins Medicine leaders to improve the safety, usability, and confidentiality of patient portals for youth and families, focusing on developmental, legal, and health equity issues. She is recognized as a health trailblazer for her extensive work connecting clinical trials, bench science, and health services research. Through her clinical service, scientific initiatives, and leadership roles, she has emerged as a leading advocate for adolescent and young adult health in the United States.